Your browser doesn't support javascript.
loading
Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy.
Cochrane, Tara; Enrico, Alicia; Gomez-Almaguer, David; Hadjiev, Evgueniy; Lech-Maranda, Ewa; Masszi, Tamas; Nikitin, Eugene; Robak, Tadeusz; Weinkove, Robert; Wu, Shang-Ju; Manzoor, Beenish S; Busman, Todd; Pai, Madhavi; Komlosi, Viktor; Anderson, Mary Ann.
Afiliación
  • Cochrane T; Department of Haematology, Gold Coast University Hospital, Southport, Australia.
  • Enrico A; School of Medicine, Griffiths University, Parkwood, Queensland, Australia.
  • Gomez-Almaguer D; Area Hematology, Hospital Italiano La Plata, Buenos Aires, Argentina.
  • Hadjiev E; Hematology Service, Hospital Universitario, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Mexico.
  • Lech-Maranda E; Department of Internal Medicine, Medical University Sofia, University Hospital Alexandrovska, Sofia, Bulgaria.
  • Masszi T; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Nikitin E; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.
  • Robak T; Department of Hematology, Oncology and Chemotherapy, S. P. Botkin's City Hospital, Moscow, Russia.
  • Weinkove R; Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland.
  • Wu SJ; Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital, Coast & Hutt Valley, Wellington, New Zealand.
  • Manzoor BS; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Busman T; Department of Internal Medicine, Division of Haematology, National Taiwan University Hospital, Taipei City, Taiwan.
  • Pai M; AbbVie, Inc., North Chicago, IL, USA.
  • Komlosi V; AbbVie, Inc., North Chicago, IL, USA.
  • Anderson MA; AbbVie, Inc., North Chicago, IL, USA.
Leuk Lymphoma ; : 1-4, 2023 Aug 25.
Article en En | MEDLINE | ID: mdl-37626019

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Australia